11.1 What GLP-1 Therapy Does Not Do Current evidence does not support the claim that GLP-1 receptor agonists: Cause universal micronutrient depletion Directly impair intestinal absorption Mimic bariatric malabsorption Require blanket supplementation Intestinal anatomy remains intact
GSSG, oxidised glutathione, is the spent variant that arises after GSH has performed its function
The GLP-1 Mechanism: Slowing Down the Stomach Of course, semaglutide isnt the only weight loss medication that works in this way
Patients with history of MBS are advised to consume fibre to reduce carbohydrate absorption, limit foods with a high glycemic index, prefer complex carbohydrates, and have a diet fractioned in frequent small meals [44, 47,48,49]
Similar content being viewed by others Introduction Weight regain (WR) and insufficient weight loss (IWL) are significant challenges faced by 2025% of patients following bariatric surgery, often stemming from a combination of anatomical variations, genetic predispositions, hormonal imbalances, dietary noncompliance, and inadequate physical activity [1,2,3]
If needed, they may order a metabolic test to better understand your hormone and metabolic health or support insurance coverage